Open AccessImmune thrombocytopenia management during COVID‐19 pandemic: An Italian monocentric experience
Author(s) -
Lapietra Gianfranco,
Ferretti Antonietta,
Baldacci Erminia,
Chistolini Antonio,
Santoro Cristina
Publication year - 2022
Publication title -
ejhaem
Language(s) - English
Resource type - Journals
ISSN - 2688-6146
DOI - 10.1002/jha2.406
Subject(s) - immune thrombocytopenia , medicine , pandemic , covid-19 , hematology , antibody , immune system , pediatrics , university hospital , immunology , virology , disease , infectious disease (medical specialty) , outbreak
Over the last 2 years, different cases of immune thrombocytopenia (ITP) in patients affected by SARS‐CoV2 have been reported. The management of SARS‐CoV2 in subjects with simultaneous or previous ITP can be challenging because of the great involvement of the haemostatic system in this viral infection. In this report, we describe the management and outcome of patients with newly diagnosed (ND), chronic and previous ITP, infected by COVID‐19, referred to the Haematology Institute of University Hospital Policlinico Umberto I in Rome. Steroids + immunoglobulins for ND or relapsed ITP and continuation of home therapy for chronic ITP are advised, although further knowledge is required.